Skip to main navigation Skip to search Skip to main content

New Type 2 Diabetes Findings Has Been Reported by Researchers at Sungkyunkwan University School of Medicine (Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naive type 2 diabetes: The EMPA-FIT study)

Press/Media

Period2025.11.21

Media coverage

1

Media coverage

  • TitleNew Type 2 Diabetes Findings Has Been Reported by Researchers at Sungkyunkwan University School of Medicine (Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naive type 2 diabetes: The EMPA-FIT study)
    Media name/outletNewsRx Diabetes Daily
    Country/TerritoryUnited States
    Date25.11.21
    PersonsSooman Lim